Treatment-Resistant Hypertension and the Incidence of Cardiovascular Disease and End-Stage Renal Disease-Reference-Cited by-同舟云学术

Treatment-Resistant Hypertension and the Incidence of Cardiovascular Disease and End-Stage Renal Disease

Published:2014-11 Issue:5 Volume:64 Page:1012-1021
ISSN:0194-911X
Container-title:Hypertension
language:en
Short-container-title:Hypertension

Author:

Muntner Paul¹,Davis Barry R.¹,Cushman William C.¹,Bangalore Sripal¹,Calhoun David A.¹,Pressel Sara L.¹,Black Henry R.¹,Kostis John B.¹,Probstfield Jeffrey L.¹,Whelton Paul K.¹,Rahman Mahboob¹

Affiliation:

1. From the Department of Epidemiology (P.M.) and Cardiovascular Disease (D.A.C.), University of Alabama at Birmingham; Coordinating Center for Clinical Trials, The University of Texas School of Public Health, Houston (B.R.D., S.L.P.); Preventive Medicine Section, Memphis Veterans Affairs Medical Center, TN (W.C.C.); Cardiovascular Outcomes Group, New York University School of Medicine (S.B.); New York University Langone Medical Center (H.R.B.); Rutgers Robert Wood Johnson Medical School, New Brunswick...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

Reference24 articles.

1. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

2. Elevated systolic blood pressure and risk of cardiovascular and renal disease: Overview of evidence from observational epidemiologic studies and randomized controlled trials

3. Resistant Hypertension: Diagnosis, Evaluation, and Treatment

4. Uncontrolled and Apparent Treatment Resistant Hypertension in the United States, 1988 to 2008

5. Prevalence and Correlates of Low Medication Adherence in Apparent Treatment-Resistant Hypertension

Cited by 190 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renal Denervation in End-Stage Renal Disease: Current Evidence and Perspectives;High Blood Pressure & Cardiovascular Prevention;2024-01-25

2. Resistant hypertension: consensus document from the Korean society of hypertension;Clinical Hypertension;2023-11-01

3. Characteristics and Predictors of Apparent Treatment-Resistant Hypertension in Real-World Populations Using Electronic Health Record-Based Data;American Journal of Hypertension;2023-09-15

4. New Therapy Update Aprocitentan: An Endothelin Receptor Antagonist for the Treatment of Drug-Resistant Systemic Hypertension;Cardiology in Review;2023-08-02

5. Lifestyle Medicine as a Treatment for Resistant Hypertension;Current Hypertension Reports;2023-07-20